BGD Stock Overview
Develops, produces, and distributes pharmaceutical products in Poland.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Biogened S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł22.80 |
| 52 Week High | zł32.60 |
| 52 Week Low | zł13.60 |
| Beta | 0.69 |
| 11 Month Change | 5.56% |
| 3 Month Change | -11.63% |
| 1 Year Change | 33.33% |
| 33 Year Change | 135.05% |
| 5 Year Change | 204.00% |
| Change since IPO | -43.00% |
Recent News & Updates
Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding
May 23
Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden
May 09Recent updates
Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding
May 23Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden
May 09Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations
Feb 21Is Biogened (WSE:BGD) A Risky Investment?
Feb 01Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump
Feb 01We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt
Jun 30Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly
Oct 08Is Biogened (WSE:BGD) A Risky Investment?
Jun 29Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?
Mar 25These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well
Dec 09Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet
Jul 29Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly
Apr 30Is Biogened (WSE:BGD) A Risky Investment?
Jan 24Shareholder Returns
| BGD | PL Pharmaceuticals | PL Market | |
|---|---|---|---|
| 7D | 6.5% | 7.6% | -2.9% |
| 1Y | 33.3% | 35.7% | 12.5% |
Return vs Industry: BGD underperformed the Polish Pharmaceuticals industry which returned 38.5% over the past year.
Return vs Market: BGD exceeded the Polish Market which returned 12.8% over the past year.
Price Volatility
| BGD volatility | |
|---|---|
| BGD Average Weekly Movement | 14.0% |
| Pharmaceuticals Industry Average Movement | 5.0% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in PL Market | 9.0% |
| 10% least volatile stocks in PL Market | 3.2% |
Stable Share Price: BGD's share price has been volatile over the past 3 months.
Volatility Over Time: BGD's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of Polish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 204 | Andrzej Grzegorzewski | www.biogened.pl |
Biogened S.A. develops, produces, and distributes pharmaceutical products in Poland. The company offers dermo-cosmetics under the Dermedic brand; and thermal water. It also exports its products.
Biogened S.A. Fundamentals Summary
| BGD fundamental statistics | |
|---|---|
| Market cap | zł56.00m |
| Earnings (TTM) | zł4.43m |
| Revenue (TTM) | zł99.61m |
12.7x
P/E Ratio0.6x
P/S RatioIs BGD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BGD income statement (TTM) | |
|---|---|
| Revenue | zł99.61m |
| Cost of Revenue | zł32.39m |
| Gross Profit | zł67.22m |
| Other Expenses | zł62.79m |
| Earnings | zł4.43m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 14, 2024
| Earnings per share (EPS) | 1.80 |
| Gross Margin | 67.48% |
| Net Profit Margin | 4.44% |
| Debt/Equity Ratio | 48.6% |
How did BGD perform over the long term?
See historical performance and comparisonDividends
2.2%
Current Dividend Yield28%
Payout RatioDoes BGD pay a reliable dividends?
See BGD dividend history and benchmarks| Biogened dividend dates | |
|---|---|
| Ex Dividend Date | Sep 12 2024 |
| Dividend Pay Date | Nov 18 2024 |
| Days until Ex dividend | 52 days |
| Days until Dividend pay date | 119 days |
Does BGD pay a reliable dividends?
See BGD dividend history and benchmarks